There are 57 million women aged 40-64 in the United States, representing the fastest-growing segment of the population. Despite this demographic shift, the healthcare system is failing to adequately treat this population during a critical life stage: 84% of these women experience menopause symptoms that diminish their quality of life, and 59% have missed work due to these symptoms.

The gap in care is driven by a lack of training and a shortage of providers. Only 20% of OB/GYNs receive specific training for treating women over 40, and 49% of U.S. counties have no OB/GYNs at all. This lack of effective treatment means women are more likely to require acute care responses, such as ER visits, and are more likely to leave the workforce entirely.

Solution

Midi Health is the leader in women’s virtual healthcare providing comprehensive, personalized treatment for perimenopause, menopause, hormonal health, and chronic conditions. Positioning itself as the "digital front door" to healthcare for women in midlife, Midi combines clinical rigor with a scalable, AI-enabled care delivery model.

The company utilizes a virtual, nurse-practitioner-led model to bypass geographic constraints, providing access in healthcare deserts where specialized support is otherwise nonexistent. Midi’s offerings include virtual consults, custom compounded prescriptions (such as HRT and GLP1s), and supplements. Midi has secured broad insurance coverage across all 50 states, covering 80% of PPO plans and over 45 million women.

Midi operates as an AI-enabled clinic, utilizing a proprietary platform to create leverage by offering real-time clinical decision support that enables nurse practitioners to deliver high-quality, standardized care at scale. The platform also automates administrative tasks such as documentation and claims processing, thereby significantly reducing provider burden. By shifting non-clinical tasks to AI, Midi allows providers to focus on the patient, driving attractive gross margins while maintaining high satisfaction rates.

Why We Invested

Midi Health addresses a massive, underserved market supported by cultural tailwinds that are increasingly destigmatizing menopause and encouraging women to seek care. The company has demonstrated an impressive growth trajectory and is widely recognized as a category leader.

The company has created a significant strategic moat through its insurance relationships and enterprise partnerships with major employers. Midi achieves impressive unit economics by leveraging a proprietary AI platform to reduce administrative burdens by 30-50%, driving clinical efficiency and margin expansion without sacrificing care quality.

We are also backing a proven, mission-driven leadership team. CEO Joanna Strober is a repeat entrepreneur surrounded by a multidisciplinary executive team with direct experience scaling consumer health unicorns, including former executives from Hims & Hers and Tia.

Impact

Midi Health is closing a critical access gap in women's health. By securing commercial insurance contracts that cover 80% of all PPO plans, the company ensures that high-quality menopause care is accessible and affordable. This is particularly vital given that nearly half of U.S. counties lack OB/GYN specialists.

The clinical impact on this population is significant: 91% of Midi patients report symptom improvement. This level of care translates to high engagement, with a 95% patient satisfaction rate. Beyond individual health, Midi supports economic equity by helping women manage symptoms that might otherwise force them to miss work or retire early.